Your browser doesn't support javascript.
loading
Janus kinase inhibitor Abrocitinib as an Off-Label treatment for tattoo granuloma with uveitis (TAGU).
Yang, Yutong; Yan, Jia; Yang, Jin; Wang, Peiru; Liu, Yeqiang; Wang, Xiuli.
Affiliation
  • Yang Y; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Yan J; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Yang J; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang P; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
  • Liu Y; Department of Dermatopathology, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Wang X; Institute of Photomedicine, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China.
Australas J Dermatol ; 65(3): 297-299, 2024 May.
Article in En | MEDLINE | ID: mdl-38450752

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tattooing / Uveitis / Off-Label Use / Janus Kinase Inhibitors Limits: Adult / Female / Humans / Male Language: En Journal: Australas J Dermatol Year: 2024 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tattooing / Uveitis / Off-Label Use / Janus Kinase Inhibitors Limits: Adult / Female / Humans / Male Language: En Journal: Australas J Dermatol Year: 2024 Type: Article Affiliation country: China